Vasileios Askoxylakis

4.1k total citations · 1 hit paper
49 papers, 2.5k citations indexed

About

Vasileios Askoxylakis is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vasileios Askoxylakis has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Molecular Biology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vasileios Askoxylakis's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Peptidase Inhibition and Analysis (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Vasileios Askoxylakis is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Peptidase Inhibition and Analysis (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Vasileios Askoxylakis collaborates with scholars based in Germany, United States and United Kingdom. Vasileios Askoxylakis's co-authors include Rakesh K. Jain, Dai Fukumura, Meenal Datta, Jürgen Debus, Moungi G. Bawendi, Jessica A. Carr, Oliver T. Bruns†, Daniel Franke, Collin F. Perkinson and Justin R. Caram and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Vasileios Askoxylakis

49 papers receiving 2.5k citations

Hit Papers

Shortwave infrared fluore... 2018 2026 2020 2023 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
    2018 565 citations Jessica A. Carr, Daniel Franke et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasileios Askoxylakis Germany 25 854 754 735 477 390 49 2.5k
Meenal Datta United States 17 956 1.1× 765 1.0× 569 0.8× 188 0.4× 322 0.8× 42 2.6k
Paula J. Foster Canada 33 1.1k 1.3× 667 0.9× 1.0k 1.4× 770 1.6× 442 1.1× 114 3.4k
Dorothy A. Sipkins United States 18 415 0.5× 803 1.1× 1.1k 1.5× 415 0.9× 245 0.6× 30 3.0k
Michael T. Spiotto United States 27 645 0.8× 1.6k 2.1× 763 1.0× 352 0.7× 926 2.4× 99 3.8k
Mahaveer S. Bhojani United States 23 735 0.9× 749 1.0× 1.4k 1.9× 264 0.6× 331 0.8× 37 2.8k
Johannes S. de Jong Netherlands 13 966 1.1× 626 0.8× 635 0.9× 420 0.9× 613 1.6× 14 2.5k
Jay F. Dorsey United States 31 690 0.8× 826 1.1× 1.1k 1.5× 296 0.6× 740 1.9× 80 3.1k
Pilar de la Puente United States 22 609 0.7× 717 1.0× 1.2k 1.6× 232 0.5× 269 0.7× 50 2.7k
James Paget United Kingdom 10 518 0.6× 791 1.0× 587 0.8× 230 0.5× 399 1.0× 21 1.9k
Dawen Zhao United States 33 610 0.7× 581 0.8× 1.3k 1.7× 923 1.9× 490 1.3× 73 3.5k

Countries citing papers authored by Vasileios Askoxylakis

Since Specialization
Citations

This map shows the geographic impact of Vasileios Askoxylakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasileios Askoxylakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasileios Askoxylakis more than expected).

Fields of papers citing papers by Vasileios Askoxylakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasileios Askoxylakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasileios Askoxylakis. The network helps show where Vasileios Askoxylakis may publish in the future.

Co-authorship network of co-authors of Vasileios Askoxylakis

This figure shows the co-authorship network connecting the top 25 collaborators of Vasileios Askoxylakis. A scholar is included among the top collaborators of Vasileios Askoxylakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasileios Askoxylakis. Vasileios Askoxylakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jankú, Filip, Sae‐Won Han, Toshihiko Doi, et al.. (2022). Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies. Cancer Immunology Research. 10(12). 1441–1461. 46 indexed citations
2.
Knee, Deborah, Feng Gao, Keith G. Mansfield, et al.. (2022). A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies. Blood. 140(Supplement 1). 11564–11565. 4 indexed citations
3.
4.
Kamoun, Walid S., Anne‐Sophie Dugast, James Suchy, et al.. (2019). Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models. Molecular Cancer Therapeutics. 19(1). 270–281. 15 indexed citations
5.
Pace, Emily A., Sharlene Adams, Michael D. Curley, et al.. (2018). Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer. Clinical Cancer Research. 24(12). 2873–2885. 44 indexed citations
6.
Carr, Jessica A., Daniel Franke, Justin R. Caram, et al.. (2018). Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green. Proceedings of the National Academy of Sciences. 115(17). 4465–4470. 565 indexed citations breakdown →
7.
8.
Askoxylakis, Vasileios, Mark Badeaux, Sylvie Roberge, et al.. (2017). A cerebellar window for intravital imaging of normal and disease states in mice. Nature Protocols. 12(11). 2251–2262. 19 indexed citations
9.
Askoxylakis, Vasileios, Costas Arvanitis, Christina S.F. Wong, Gino B. Ferraro, & Rakesh K. Jain. (2017). Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors. Advanced Drug Delivery Reviews. 119. 159–174. 24 indexed citations
10.
Nia, Hadi T., Hao Liu, Giorgio Seano, et al.. (2016). Solid stress and elastic energy as measures of tumour mechanopathology. Nature Biomedical Engineering. 1(1). 315 indexed citations
11.
Askoxylakis, Vasileios, Gino B. Ferraro, David P. Kodack, et al.. (2015). Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment. JNCI Journal of the National Cancer Institute. 108(2). 57 indexed citations
12.
Kodack, David P., Vasileios Askoxylakis, Gino B. Ferraro, Dai Fukumura, & Rakesh K. Jain. (2015). Emerging Strategies for Treating Brain Metastases from Breast Cancer. Cancer Cell. 27(2). 163–175. 106 indexed citations
13.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2012). Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor‐Targeting Miniproteins. Angewandte Chemie International Edition. 51(52). 13136–13139. 36 indexed citations
14.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2012). Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor‐Targeting Miniproteins. Angewandte Chemie. 124(52). 13313–13316. 10 indexed citations
15.
Askoxylakis, Vasileios, Annette Altmann, Annette Markert, et al.. (2012). Peptide-Based Targeting of the Platelet-Derived Growth Factor Receptor Beta. Molecular Imaging and Biology. 15(2). 212–221. 28 indexed citations
16.
Askoxylakis, Vasileios, Gunda Millonig, Ute Wirkner, et al.. (2011). Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency. Radiation Oncology. 6(1). 35–35. 17 indexed citations
17.
Markert, Annette, et al.. (2011). Biotechnology techniques for the development of new tumor specific peptides. Methods. 55(3). 215–222. 15 indexed citations
18.
Altmann, Annette, Michael Eisenhut, Ulrike Bauder‐Wüst, et al.. (2010). Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275. European Journal of Nuclear Medicine and Molecular Imaging. 37(12). 2286–2297. 14 indexed citations
19.
Askoxylakis, Vasileios, Jürgen Debus, & Marc Bischof. (2010). Radiotherapy of skin cancers. Expert Review of Dermatology. 5(2). 173–181. 4 indexed citations
20.
Askoxylakis, Vasileios, Susanne Krämer, Ulrike Hebling, et al.. (2010). A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology. PLoS ONE. 5(12). e15962–e15962. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meenal Datta Breakdown of academic impact, for papers by Paula J. Foster Breakdown of academic impact, for papers by Dorothy A. Sipkins Breakdown of academic impact, for papers by Michael T. Spiotto Breakdown of academic impact, for papers by Mahaveer S. Bhojani Breakdown of academic impact, for papers by Johannes S. de Jong Breakdown of academic impact, for papers by Jay F. Dorsey Breakdown of academic impact, for papers by Pilar de la Puente Breakdown of academic impact, for papers by James Paget Breakdown of academic impact, for papers by Dawen Zhao
Rankless by CCL
2026